Upstream therapy of atrial fibrillation (Q37546133)

20 August 2017

1 reference

title

Upstream therapy of atrial fibrillation (English)

1 reference

20 August 2017

0 references

Isabelle C Van Gelder

series ordinal

object named as

Isabelle C Van Gelder

1 reference

20 August 2017

Marcelle D Smit

1 reference

20 August 2017

publication date

1 July 2009

1 reference

Expert Review of Cardiovascular Therapy

20 August 2017

published in

1 reference

20 August 2017

1 reference

20 August 2017

1 reference

20 August 2017

page(s)

763-778

1 reference

Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial

20 August 2017

cites work

1 reference

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

Rhythm control versus rate control for atrial fibrillation and heart failure

21 January 2018

1 reference

Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study

21 January 2018

1 reference

Is atrial fibrillation an inflammatory disorder?

21 January 2018

1 reference

Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data

21 January 2018

1 reference

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

21 January 2018

1 reference

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode

21 January 2018

1 reference

The renin-angiotensin system: a therapeutic target in atrial fibrillation

21 January 2018

1 reference

Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling

21 January 2018

1 reference

Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanisms

21 January 2018

1 reference

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

21 January 2018

1 reference

Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure

21 January 2018

1 reference

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.

21 January 2018

1 reference

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study

21 January 2018

1 reference

Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial

21 January 2018

1 reference

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

21 January 2018

1 reference

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.

21 January 2018

1 reference

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

21 January 2018

1 reference

Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study

21 January 2018

1 reference

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation

21 January 2018

1 reference

Prevention of recurrent lone atrial fibrillation by the angiotensin-II converting enzyme inhibitor ramipril in normotensive patients.

21 January 2018

1 reference

Valsartan for prevention of recurrent atrial fibrillation

21 January 2018

1 reference

Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association

21 January 2018

1 reference

Beneficial effect of eplerenone on cardiac remodelling and electrical properties of the failing heart

21 January 2018

1 reference

Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction

21 January 2018

1 reference

Spironolactone Reduced Arrhythmia and Maintained Magnesium Homeostasis in Patients With Congestive Heart Failure

21 January 2018

1 reference

Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure

21 January 2018

1 reference

Do statins have an antiarrhythmic activity?

21 January 2018

1 reference

Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

21 January 2018

1 reference

Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs

21 January 2018

1 reference

The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model

21 January 2018

1 reference

Antiarrhythmic effect of statin therapy and atrial fibrillation a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein

21 January 2018

1 reference

Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation

21 January 2018

1 reference

The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery

21 January 2018

1 reference

Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients.

21 January 2018

1 reference

Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery

21 January 2018

1 reference

Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.

21 January 2018

1 reference

Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial

21 January 2018

1 reference

Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure

21 January 2018

1 reference

Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.

21 January 2018

1 reference

Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials

21 January 2018

1 reference

Statin use and recurrence of atrial fibrillation after successful cardioversion

21 January 2018

1 reference

Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion

21 January 2018

1 reference

Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study

21 January 2018

1 reference

Effect of C-reactive protein reduction on paroxysmal atrial fibrillation

21 January 2018

1 reference

Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation.

21 January 2018

1 reference

Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial

21 January 2018

1 reference

Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers

21 January 2018

1 reference

Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy

21 January 2018

1 reference

Fish intake, contaminants, and human health: evaluating the risks and the benefits

21 January 2018

1 reference

Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office Of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmo

21 January 2018

1 reference

Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes

21 January 2018

1 reference

Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling

21 January 2018

1 reference

Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction

21 January 2018

1 reference

N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.

21 January 2018

1 reference

Fish intake and risk of incident atrial fibrillation

21 January 2018

1 reference

Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study

21 January 2018

1 reference

Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs

21 January 2018

1 reference

Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery

21 January 2018

1 reference

Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial

21 January 2018

1 reference

Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation

21 January 2018

1 reference

Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation

21 January 2018

1 reference

Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation

21 January 2018

1 reference

Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure

21 January 2018

1 reference

Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure

21 January 2018

1 reference

Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study

21 January 2018

1 reference

Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals.

21 January 2018

1 reference

Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERC.09.59

1 reference

20 August 2017

1 reference